MOTS-c safety data is limited to animal studies and the CB4211 analog Phase 1 trial
We also repeat labs around week twelve, checking A1c, lipids, kidney, and liver function, so tolerance and metabolic improvement are tracked together rather than guessed at
GLP-1 medications have become an increasingly popular solution for peoples weight loss woes
It is possible, as the authors imply, that there might be some other anti-inflammatory benefits that are having an outcome on cancer risk reduction. Wolff-Sagy shared that future work would involve looking at other cohort studies, expanding the demographics and timeframe of the study, and digging into the molecular mechanisms behind GLP-1 treatments
Amnas clinic, your safety and results always come first